Impact of Sugammadex vs. Neostigmine Reversal on Post-Operative Recovery And Postoperative Complications In Patients With Obstructive Sleep Apnea Undergoing Bariatric Surgery: A Double-Blind, Randomized Controlled Trial
Latest Information Update: 24 Mar 2025
At a glance
- Drugs Sugammadex (Primary) ; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
Most Recent Events
- 13 Oct 2022 Status changed from recruiting to completed.
- 27 Oct 2021 Planned End Date changed from 30 Jun 2021 to 31 Jan 2022.
- 27 Oct 2021 Planned primary completion date changed from 30 May 2021 to 30 Dec 2021.